Tet2-Clonal Hematopoiesis Promotes Whereas Dnmt3a-CH Inhibits Breast Cancer Progression During Aging
Nagihan G. Gonullu, Karolina A. Zielinska, Jonas Fullin…·Markus G. Manz
This study shows that Tet2-mutant clonal hematopoiesis promotes while Dnmt3a-mutant clonal hematopoiesis inhibits breast cancer progression with age, identifying IL-1/CXCL2 inflammation as a therapeutic target.